TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis

scientific article published on 29 July 2013

TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/NEUP.12053
P698PubMed publication ID23889603
P5875ResearchGate publication ID253331693

P2093author name stringHitoshi Takahashi
Yasuko Toyoshima
P2860cites workAtaxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSQ24297462
Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUSQ24634807
TDP-43 aggregation in neurodegeneration: are stress granules the key?Q27692111
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisQ28131672
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosisQ28270779
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosisQ29615597
Ubiquitinated filamentous inclusions in cerebellar dentate nucleus neurons in dentatorubral-pallidoluysian atrophy contain expanded polyglutamine stretchesQ33906927
Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsyQ33984304
Pathology of CAG repeat diseasesQ34158005
The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.Q34263380
Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS)Q34304833
Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer diseaseQ36115656
Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansionsQ36528554
Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic studyQ36534978
Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathiesQ36860214
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's diseaseQ37179756
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype.Q37425165
Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington diseaseQ45291590
The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseasesQ45295489
Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodiesQ46396965
TDP-43 mutation in familial amyotrophic lateral sclerosisQ46625104
Effect of topographical distribution of α-synuclein pathology on TDP-43 accumulation in Lewy body disease.Q47608338
Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathologyQ47861971
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseasesQ48095281
RNA-binding proteins in neurological diseaseQ48478890
Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph diseaseQ48570252
TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotypeQ48864196
Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathologyQ48955730
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.Q53299106
P433issue1
P304page(s)77-82
P577publication date2013-07-29
P1433published inNeuropathologyQ15761930
P1476titleTDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis
P478volume34

Reverse relations

cites work (P2860)
Q30418368Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model.
Q48111333Cardiac Arrest Alters Regional Ubiquitin Levels in Association with the Blood-Brain Barrier Breakdown and Neuronal Damages in the Porcine Brain
Q58712192Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy
Q33902853Elimination of undifferentiated human embryonic stem cells by cardiac glycosides
Q36594209GGGGCC microsatellite RNA is neuritically localized, induces branching defects, and perturbs transport granule function
Q26773168Golgi Fragmentation in ALS Motor Neurons. New Mechanisms Targeting Microtubules, Tethers, and Transport Vesicles
Q47693846The roles of intrinsic disorder-based liquid-liquid phase transitions in the "Dr. Jekyll-Mr. Hyde" behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Q30635379YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1.

Search more.